The interaction between aspirin and losartan on cardiovascular morbidity and mortality in patients with hypertension and left ventricular hypertrophy. A losartan intervention for endpoint reduction (LIFE) substudy

被引：0
|
作者：
Fossum, E
Kjeldsen, SE
Dahlof, B
Devereux, RB
Julius, S
Snapinn, S
机构：
[1] Ullevaal Univ Hosp, Dept Cardiol, Oslo, Norway
[2] Sahlgrens Univ Hosp, Dept Med, S-41345 Gothenburg, Sweden
[3] Cornell Med Ctr, Div Cardiol, New York, NY USA
[4] Univ Michigan, Dept Internal Med, Div Hypertens, Ann Arbor, MI 48109 USA
[5] Merck & Co Inc, Whitehouse Stn, NJ USA
来源：
AMERICAN JOURNAL OF HYPERTENSION | 2003年 / 16卷 / 05期
关键词：
losartan; aspirin; atenolol;
D O I：
10.1016/S0895-7061(03)00111-0
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
OR27
引用
收藏
页码：11A / 12A
页数：2
相关论文
共 50 条
  • [1] The interaction between aspirin and losartan on cardiovascular morbidity and mortality in patients with hypertension and left ventricular hypertrophy.: A losartan intervention for endpoint reduction (life) substudy
    Fossum, E
    Kjeldsen, SE
    Dahlöf, B
    Devereux, RB
    Julius, S
    Snappin, S
    JOURNAL OF HYPERTENSION, 2003, 21 : S118 - S118
  • [2] Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy -: A Losartan Intervention For Endpoint Reduction (LIFE) substudy
    Kjeldsen, SE
    Dahlöf, B
    Devereux, RB
    Julius, S
    Aurup, P
    Edelman, J
    Beevers, G
    de Faire, U
    Fyhrquist, F
    Ibsen, H
    Kristianson, K
    Lederballe-Pedersen, O
    Lindholm, LH
    Nieminen, MS
    Omvik, P
    Oparil, S
    Snapinn, S
    Wedel, H
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (12): : 1491 - 1498
  • [3] Effect of losartan compared to atenolol on cardiovascular mortality and morbidity in high and low risk patients with left ventricular hypertrophy.: A losartan intervention for endpoint reduction -: The LIFE study
    Franklin, SS
    Wachtell, K
    Papademetriou, V
    Olsen, MH
    Ibsen, H
    Kjeldsen, SE
    Devereux, RB
    Julius, S
    Dahlöf, B
    JOURNAL OF HYPERTENSION, 2003, 21 : S67 - S67
  • [4] Losartan for the treatment of hypertension and left ventricular hypertrophy: the Losartan intervention for endpoint reduction in hypertension (LIFE) study
    Devereux, RB
    Lyle, PA
    EXPERT OPINION ON PHARMACOTHERAPY, 2004, 5 (11) : 2311 - 2320
  • [5] The effect of losartan versus atenolol on cardiovascular morbidity and mortality in patients with hypertension taking aspirin -: The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) study
    Fossum, E
    Moan, A
    Kjeldsen, SE
    Devereux, RB
    Julius, S
    Snapinn, SM
    Edelman, JM
    de Faire, U
    Fyhrquist, F
    Ibsen, H
    Kristianson, K
    Lederballe-Pedersen, O
    Lindholm, LH
    Nieminen, MS
    Omvik, P
    Oparil, S
    Wedel, H
    Dahlöf, B
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 46 (05) : 770 - 775
  • [6] Left bundle branch block and cardiovascular morbidity and mortality in hypertensive patients with left ventricular hypertrophy:: the Losartan Intervention For Endpoint Reduction in Hypertension study
    Li, Zhibin
    Dahlof, Bjorn
    Okin, Peter M.
    Kjeldsen, Sverre E.
    Wachtell, Kristian
    Ibsen, Hans
    Nieminen, Markku S.
    Jern, Sverker
    Devereux, Richard B.
    JOURNAL OF HYPERTENSION, 2008, 26 (06) : 1244 - 1249
  • [7] A Point System Table to Estimate the Risk of Cardiovascular Events in Patients With Hypertension and Left Ventricular Hypertrophy. The Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study
    Hille, Darcy
    Kjeldsen, Sverre E.
    Dahloef, Bjoern
    Edelman, Jonathan M.
    Devereux, Richard B.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (10) : A214 - A214
  • [8] Predictors of cardiovascular events in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention For Endpoint reduction in hypertension study
    Kjeldsen, Sverre E.
    Devereux, Richard B.
    Hille, Darcy A.
    Lyle, Paulette A.
    Dahlof, Bjorn
    Julius, Stevo
    Edelman, Jonathan M.
    Snapinn, Steven M.
    De Faire, Ulf
    Fyhrquist, Frej
    Ibsen, Hans
    Lederballe-Pedersen, Ole
    Lindholm, Lars H.
    Nieminen, Markku S.
    Omvik, Per
    Oparil, Suzanne
    Wedel, Hans
    BLOOD PRESSURE, 2009, 18 (06) : 348 - 361
  • [9] Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol -: The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial
    Devereux, RB
    Dahlöf, B
    Gerdts, E
    Boman, K
    Nieminen, MS
    Papademetriou, V
    Rokkedal, J
    Harris, KE
    Edelman, JM
    Wachtell, K
    CIRCULATION, 2004, 110 (11) : 1456 - 1462
  • [10] Regression of electrocardiographic left ventricular hypertrophy by Losartan versus atenolol -: The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) Study
    Okin, PM
    Devereux, RB
    Jern, S
    Kjeldsen, SE
    Julius, S
    Nieminen, MS
    Snapinn, S
    Harris, KE
    Aurup, P
    Edelman, JM
    Dahlöf, B
    CIRCULATION, 2003, 108 (06) : 684 - 690
12345